Athersys

Neurona Therapeutics

This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.

Promethera

The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.

Alder Therapeutics

This company develops allogeneic stem cell therapies to treat patients with retinitis pigmentosa and chronic heart failure.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

Neuroplast

This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.

Aegle Therapeutics

This company develops extracellular vesicle therapies derived from stem cells to treat patients with rare dermatological disorders and severe burns.

ASHVATTHA THERAPEUTICS

This clinical-stage biopharmaceutical company develops targeted nanomedicine therapeutics for patients with inflammatory, neurological, and ophthalmic diseases including age-related macular degeneration.

Tengion Inc

This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.